Maxime Cazorla

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. ncbi Cyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in mice
    Maxime Cazorla
    Neurobiology and Molecular Pharmacology, Centre de Psychiatrie et de Neurosciences, UMR 894 INSERM Université Paris Descartes, Paris, France
    PLoS ONE 5:e9777. 2010
  2. ncbi Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor
    M Cazorla
    Laboratory of Neurobiology and Molecular Pharmacology, Centre de psychiatrie et Neurosciences, UMR 894 INSERM Université Paris Descartes, 2ter rue d Alesia, Paris, France
    Br J Pharmacol 162:947-60. 2011
  3. ncbi Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice
    Maxime Cazorla
    Neurobiology and Molecular Pharmacology, Centre de psychiatrie et Neurosciences, UMR 894 INSERM Université Paris Descartes, Paris, France
    J Clin Invest 121:1846-57. 2011

Detail Information

Publications3

  1. ncbi Cyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in mice
    Maxime Cazorla
    Neurobiology and Molecular Pharmacology, Centre de Psychiatrie et de Neurosciences, UMR 894 INSERM Université Paris Descartes, Paris, France
    PLoS ONE 5:e9777. 2010
    ....
  2. ncbi Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor
    M Cazorla
    Laboratory of Neurobiology and Molecular Pharmacology, Centre de psychiatrie et Neurosciences, UMR 894 INSERM Université Paris Descartes, 2ter rue d Alesia, Paris, France
    Br J Pharmacol 162:947-60. 2011
    ..In this study, we used an antibody-based approach to search for trkB-selective functional reagents...
  3. ncbi Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice
    Maxime Cazorla
    Neurobiology and Molecular Pharmacology, Centre de psychiatrie et Neurosciences, UMR 894 INSERM Université Paris Descartes, Paris, France
    J Clin Invest 121:1846-57. 2011
    ..We further propose that ANA-12 may be a valuable tool for studying BDNF/TrkB signaling and may constitute a lead compound for developing the next generation of therapeutic agents for the treatment of mood disorders...